UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Journal of clinical oncology, 2009-06, Vol.27 (16), p.2686-2691

2009

Volltextzugriff (PDF)

Cervical cancer

The Lancet (British edition), 2003-06, Vol.361 (9376), p.2217-2225

Waggoner, Steven E

2003

Volltextzugriff (PDF)

Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy

Gynecologic oncology, 2011-08, Vol.122 (2), p.328-333

2011

Volltextzugriff (PDF)

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

The Lancet (British edition), 2017-10, Vol.390 (10103), p.1654-1663

2017

Volltextzugriff (PDF)

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

Gynecologic oncology, 2011-02, Vol.120 (2), p.224-228

2011

Volltextzugriff (PDF)

Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

Frontiers in oncology, 2015-06, Vol.5, p.126-126

2015

Volltextzugriff (PDF)

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Journal of clinical oncology, 2022-07, Vol.40 (19), p.2138-2147

2022

Volltextzugriff (PDF)

Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study

American journal of obstetrics and gynecology, 2010-03, Vol.202 (3), p.283.e1-283.e7

2010

Volltextzugriff (PDF)

Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3

Gynecologic oncology, 2023-11, Vol.178, p.102-109

2023

Volltextzugriff (PDF)

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Gynecologic oncology, 2021-09, Vol.162 (3), p.532-538

2021

Volltextzugriff (PDF)

Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group

Journal of clinical oncology, 2003-11, Vol.21 (22), p.4207-4213

2003

Volltextzugriff (PDF)

The effect of sleep disturbance on quality of life in women with ovarian cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.351-355

2011

Volltextzugriff (PDF)

Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial

Gynecologic oncology, 2008-04, Vol.109 (1), p.19-26

2008

Volltextzugriff (PDF)

Lifestyle challenges in endometrial cancer survivorship

Obstetrics and gynecology (New York. 1953), 2011-01, Vol.117 (1), p.93-100

2011

Volltextzugriff (PDF)

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

International journal of radiation oncology, biology, physics, 2002-04, Vol.52 (5), p.1330-1337

2002

Volltextzugriff (PDF)

Abdominopelvic MR to CT registration using a synthetic CT intermediate

Journal of applied clinical medical physics, 2022-09, Vol.23 (9), p.e13731-n/a

2022

Volltextzugriff (PDF)

Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group Study

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1021-1029

2001

Volltextzugriff (PDF)

A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2015-07, Vol.138 (1), p.36-40

2015

Volltextzugriff (PDF)

Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study

Gynecologic oncology, 2006-12, Vol.103 (3), p.853-858

2006

Volltextzugriff (PDF)

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

International journal of radiation oncology, biology, physics, 2001-08, Vol.50 (5), p.1145-1153

2001

Volltextzugriff (PDF)

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic oncology, 2012-12, Vol.127 (3), p.506-510

2012

Volltextzugriff (PDF)

Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers

JNCI : Journal of the National Cancer Institute, 1997-06, Vol.89 (12), p.868-873

1997

Volltextzugriff (PDF)

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients

International journal of radiation oncology, biology, physics, 2005-03, Vol.61 (4), p.1078-1086

2005

Volltextzugriff (PDF)

A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study

Obstetrical & gynecological survey, 2015-10, Vol.70 (10), p.626-628

2015

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(56)
Female
(50)
Humans
(48)
Oncology
(45)
Middle Aged
(33)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Obstetrics & Gynecology
(28)
Adult
(26)
Aged
(26)
Tumors
(21)
Female Genital Diseases
(18)
Gynecology. Andrology. Obstetrics
(18)
Ovarian Neoplasms - Drug Therapy
(15)
Aged, 80 And Over
(14)
Drug Administration Schedule
(11)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(10)
Ovarian Cancer
(10)
Paclitaxel - Administration & Dosage
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Cervical cancer

Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapy

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: A phase I study of the Gynecologic Oncology Group

Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Smoking behavior in women with locally advanced cervical carcinoma: a Gynecologic Oncology Group study

Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3

Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis

Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group

The effect of sleep disturbance on quality of life in women with ovarian cancer

Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: A randomized trial

Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538]

Lifestyle challenges in endometrial cancer survivorship

Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies

Abdominopelvic MR to CT registration using a synthetic CT intermediate

Phase I Trial of Escalating Doses of Paclitaxel Combined With Fixed Doses of Cisplatin and Doxorubicin in Advanced Endometrial Cancer and Other Gynecologic Malignancies: A Gynecologic Oncology Group Study

A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group study

Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers

Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients

A Phase I Study of IV Doxorubicin Plus Intraperitoneal (IP) Paclitaxel and IV or IP Cisplatin in Endometrial Cancer Patients at High Risk for Peritoneal Failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group Study

Suchergebnisse filtern